Abstract
Pseudomonas aeruginosa MTCC 7925, a sludge isolate, was found to synthesize a novel short-chain-lengthlong- chain-length (SCL-LCL) co-polymer with 3-hydroxybutyric acid (3HB), 3-hydroxyvaleric acid (3HV), 3- hydroxyhexadecanoic acid (3HHD) and 3-hydroxyoctadecanoic acid (3HOD) as constituents. Under batch mode study, cells harvested at the stationary phase of growth depicted maximum PHAs accumulation, i.e. 24% of dry cell weight (dcw) at 48 h of incubation. The co-polymer accumulation was raised to 49% (dcw) under 2% ethanol-supplemented condition. A further, rise up to 78% (dcw) was recorded by optimizing the critical variables by Response Surface Methodology (RSM). When palm oil and its cakes were used as carbon sources, yield of 5.9 g/l was achieved, which was almost 85-fold higher against control. The thermal and mechanical properties of the polymer are comparable with polypropylene and polyethylene, thus opening new possibilities for various industrial applications.
Keywords: Inexpensive carbon sources, N-deficiency, P-deficiency, PHAs, Pseudomonas aeruginosa MTCC 7925, RSM, SCL-LCL-PHA co-polymer
Current Biotechnology
Title:Pseudomonas aeruginosa MTCC 7925: Producer of a Novel SCL-LCLPHA Co-Polymer
Volume: 2 Issue: 1
Author(s): Akhilesh Kumar Singh, Ranjana Bhati, Shilalipi Samantaray and Nirupama Mallick
Affiliation:
Keywords: Inexpensive carbon sources, N-deficiency, P-deficiency, PHAs, Pseudomonas aeruginosa MTCC 7925, RSM, SCL-LCL-PHA co-polymer
Abstract: Pseudomonas aeruginosa MTCC 7925, a sludge isolate, was found to synthesize a novel short-chain-lengthlong- chain-length (SCL-LCL) co-polymer with 3-hydroxybutyric acid (3HB), 3-hydroxyvaleric acid (3HV), 3- hydroxyhexadecanoic acid (3HHD) and 3-hydroxyoctadecanoic acid (3HOD) as constituents. Under batch mode study, cells harvested at the stationary phase of growth depicted maximum PHAs accumulation, i.e. 24% of dry cell weight (dcw) at 48 h of incubation. The co-polymer accumulation was raised to 49% (dcw) under 2% ethanol-supplemented condition. A further, rise up to 78% (dcw) was recorded by optimizing the critical variables by Response Surface Methodology (RSM). When palm oil and its cakes were used as carbon sources, yield of 5.9 g/l was achieved, which was almost 85-fold higher against control. The thermal and mechanical properties of the polymer are comparable with polypropylene and polyethylene, thus opening new possibilities for various industrial applications.
Export Options
About this article
Cite this article as:
Kumar Singh Akhilesh, Bhati Ranjana, Samantaray Shilalipi and Mallick Nirupama, Pseudomonas aeruginosa MTCC 7925: Producer of a Novel SCL-LCLPHA Co-Polymer, Current Biotechnology 2013; 2 (1) . https://dx.doi.org/10.2174/2211550111302010013
DOI https://dx.doi.org/10.2174/2211550111302010013 |
Print ISSN 2211-5501 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-551X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
HIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving Concepts
Infectious Disorders - Drug Targets Function and Pharmacology of Spinally-Projecting Sympathetic Pre-Autonomic Neurones in the Paraventricular Nucleus of the Hypothalamus
Current Neuropharmacology A New Approach to the Inflammatory/Autoimmune Diseases
Recent Patents on Anti-Infective Drug Discovery Retinal Ganglion Cell Gene Therapy and Visual System Repair
Current Gene Therapy The Role of α7 Nicotinic Acetylcholine Receptors and α7-Specific Antibodies in Neuroinflammation Related to Alzheimer Disease
Current Pharmaceutical Design Oxidative Biotransformation of Fatty Acids by Cytochromes P450: Predicted Key Structural Elements Orchestrating Substrate Specificity, Regioselectivity and Catalytic Efficiency
Current Drug Metabolism Inflammatory Pain: The Cellular Basis of Heat Hyperalgesia
Current Neuropharmacology Simvastatin and Other HMG-CoA Reductase Inhibitors on Brain Cholesterol Levels in Alzheimers Disease
Current Alzheimer Research Inorganic Materials for Applications in Hybrid Solar Cells
Current Inorganic Chemistry (Discontinued) The Use of the Zebrafish Model to Aid in Drug Discovery and Target Validation
Current Topics in Medicinal Chemistry Neurogenic Drugs and Compounds to Treat CNS Diseases and Disorders
Central Nervous System Agents in Medicinal Chemistry Patent Selections
Recent Patents on Anti-Infective Drug Discovery 5-HT7 Receptors
Current Drug Targets - CNS & Neurological Disorders Pharmacogenomics in the Intensive Care Unit: Focus on Potential Implications for Clinical Practice
Recent Patents on Biotechnology Safflor Protected Rat Cerebral Ischemia-Reperfusion Injury Through Inhibiting the Expression of NF-kB and IL-1β
Neuroscience and Biomedical Engineering (Discontinued) Potential Therapeutic Effects of Physical Exercise for Bipolar Disorder
CNS & Neurological Disorders - Drug Targets Targeting Inhibitor of Apoptosis Proteins (IAPs) for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Editorial (Thematic Issue: Dopamine in the Brain)
Central Nervous System Agents in Medicinal Chemistry Stress in Gastrointestinal Tract and Stable Gastric Pentadecapeptide BPC 157. Finally, do we have a Solution?
Current Pharmaceutical Design Neurodegenerative Disorders Treatment: The MicroRNA Role
Current Gene Therapy